ArticleInnovations in pharmacy2021

Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims.

Paul C LangleyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.